some excitable cell or, in contrast, that it might blunt the hypoxic response by reducing cellular metabolic rate and sensitivity to hypoxia. Thus the purpose of this study was to test in isolated rat lungs whether hypoxic pressor reactivity was related inversely or positively to Na+-K+-ATPase activity. Dose-pressor response curves to hypoxia, angiotensin II, or KC1 were measured under control conditions and after exposure either to one of two inhibitors of Na'-K'-ATPase, ouabain, and low-K+ solution or to a stimulator of Na+-K' pumping, aldosterone. Ouabain and low K' depressed the response to hypoxia but had little effect on that to angiotensin II. The response to KC1 was increased by ouabain. Aldosterone potentiated the hypoxic response. These results do not support the idea that membrane depolarization due to inhibition Na+-K' pumping is a component of hypoxic vasoconstriction. They do suggest a positive relationship between Na+-K+-ATPase activity and hypoxic pressor reactivity and are consistent with the idea that Na+-K+-ATPase activity might influence hypoxic reactivity indirectly by altering cellular energy metabolism. It is also possible that the results were somehow due to changes in intracellular [Na'] or transmembrane Na+ gradient, rather than to changes in energy metabolism. Na'-K+-ATPase; hypoxia; pulmonary vasoconstriction; oxygen sensing THE RELATIONSHIP BETWEEN the activity ofthe plasma membrane Na'-K+ pump and the basic mechanism of hypoxic pulmonary vasoconstriction is unclear (5). On the basis of existing evidence, we believe that two contradictory proposals can be made, i.e., that hypoxic pressor reactivity varies either inversely or positively with Na'-K+-ATPase activity. Bergofsky and Holtzman (1) reported that hypoxia caused isolated pulmonary arteries to lose K+ and gain Na+ and speculated that an hypoxia-induced inhibition of Na'-K+ pumping could depolarize the smooth muscle and lead to contraction. In a subsequent study, Haas et al. (10) observed that ouabain potentiated hypoxic vasoconstriction in intact animals and suggested that the potentiation was possibly due to depolarization and increased excitability of the pulmonary vascular smooth muscle. Indirect support for this suggestion has been provided by the finding that ouabain depolarizes pulmonary arterial smooth muscle in vitro (33) and by other evidence that decreased electrogenic Na+-K' pumping in vascular muscle can rapidly cause membrane depolarization and contraction (11, 13). In addition, the membrane potential and excitability of other cell types are also influenced by the activity of plasma membrane Na'-K+-ATPase (6, 34). Thus it could be postulated that pulmonary pressor reactivity to hypoxia is related inversely to the activity of the vascular smooth muscle Na+-K' pump, or even that a decrease in electrogenic Na+-K+ pumping in some excitable, O+ensitive cell, e.g., vascular smooth muscle, endothelial, neural, or secretory cell, is a necessary initial event in the hypoxic mechanism.
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Ouabain and low K' depressed the response to hypoxia but had little effect on that to angiotensin II. The response to KC1 was increased by ouabain. Aldosterone potentiated the hypoxic response. These results do not support the idea that membrane depolarization due to inhibition Na+-K' pumping is a component of hypoxic vasoconstriction. They do suggest a positive relationship between Na+-K+-ATPase activity and hypoxic pressor reactivity and are consistent with the idea that Na+-K+-ATPase activity might influence hypoxic reactivity indirectly by altering cellular energy metabolism. It is also possible that the results were somehow due to changes in intracellular [Na'] or transmembrane Na+ gradient, rather than to changes in energy metabolism. Na'-K+-ATPase; hypoxia; pulmonary vasoconstriction; oxygen sensing THE RELATIONSHIP BETWEEN the activity ofthe plasma membrane Na'-K+ pump and the basic mechanism of hypoxic pulmonary vasoconstriction is unclear (5). On the basis of existing evidence, we believe that two contradictory proposals can be made, i.e., that hypoxic pressor reactivity varies either inversely or positively with Na'-K+-ATPase activity. Bergofsky and Holtzman (1) reported that hypoxia caused isolated pulmonary arteries to lose K+ and gain Na+ and speculated that an hypoxia-induced inhibition of Na'-K+ pumping could depolarize the smooth muscle and lead to contraction. In a subsequent study, Haas et al. (10) observed that ouabain potentiated hypoxic vasoconstriction in intact animals and suggested that the potentiation was possibly due to depolarization and increased excitability of the pulmonary vascular smooth muscle. Indirect support for this suggestion has been provided by the finding that ouabain depolarizes pulmonary arterial smooth muscle in vitro (33) and by other evidence that decreased electrogenic Na+-K' pumping in vascular muscle can rapidly cause membrane depolarization and contraction (11, 13) . In addition, the membrane potential and excitability of other cell types are also influenced by the activity of plasma membrane Na'-K+-ATPase (6, 34). Thus it could be postulated that pulmonary pressor reactivity to hypoxia is related inversely to the activity of the vascular smooth muscle Na+-K' pump, or even that a decrease in electrogenic Na+-K+ pumping in some excitable, O+ensitive cell, e.g., vascular smooth muscle, endothelial, neural, or secretory cell, is a necessary initial event in the hypoxic mechanism.
On the other hand, a different effect of Na'-K+ pump activity, which might influence the mechanism by which lung tissue oxygen tension is "sensed" and the resultant hypoxic pressor reactivity, is related to cellular energy demand. Among the many processes that hydrolyze ATP in resting cells, active Na+ transport is unique in that it occurs in all cells and has been estimated to account for lo-40% of total energy consumption in various tissues (9, 14) . Changes in rate of Na+-K+ pumping will therefore affect the balance between energy supply and demand and the metabolic rate. There is evidence that cellular sensing of hypoxia, i.e., a change in cellular metabolism and activity in response to a fall in 02 tension, involves a decreased rate of mitochondrial oxidative phosphorylation and a fall in cytosolic [ATP]/ [ADP] [Pi] due to imbalance between energy supply and demand (4, 26) . Because the dependence of mitochondrial oxidative phosphorylation on O2 tension increases with respiratory rate (15, 32) and because the fall of
is a function of rate of ATP hydrolysis (4, 26), increased and decreased Na+-K' pumping could be expected to increase and decrease cellular sensitivity to hypoxia. In view of this information and the evidence that the mechanism of hypoxic pulmonary vasoconstriction also involves a decreased rate of mitochondrial oxidative phosphorylation in some lung cell (18, 28) , it could be argued that pressor reactivity to hypoxia varies positively, rather than inversely, with Na+-K+-ATPase activity.
Thus the purpose of this study was to test in isolated rat lungs whether pulmonary pressor reactivity to hypoxia varied inversely or positively with changes in lung tissue Na+-K+-ATPase activity. whereas two inhibitors of Na'-K'-ATPase, ouabain and low-K' solution (6, 34), decrease the pressor reactivity, a stimulator of Na+-K' pumping, aldosterone (7, 16, 23) , increases it.
METHODS
The experimental preparation was the isolated rat lung (12, 21) . Lungs were removed from 300-to 400-g male, Sprague-Dawley rats following anesthesia (10 mg pentobarbital/lOO g ip) and heparinization (100 IU iv). They were suspended in a humid chamber and ventilated with a warm, humid mixture of 21% O&j% COZ-74% NZ at 65 breaths/min by peak inspiratory pressure of 9 cmH20 and end-expiratory pressure of 2.5 cmH20. They were perfused by peristaltic pump through a pulmonary arterial cannula at a constant flow of 0.04 ml g body wt-'. min-' with either 20-25 ml heparinized homologous blood or 30 ml physiological salt solution. Composition of physiological salt solution was (in mM) 119 NaCl, 4.7 KCl, 1.17 MgSO,, 22.6 NaHC03,1.18 KH2P04, 3.2 CaClz, 5.5 glucose, 50 sucrose, 0.0157 sodium meclofenamate (Warner-Lambert), and 4 g/100 ml bovine albumin (fraction V, Sigma). Meclofenamate, an inhibitor of cyclooxygenase, was included because we have observed (unpub---lished data) that i pressor reactivity .t en hances and prolongs the hypoxic of salt so lution-perfused rat lungs which readily generate the vasod .ilator prostacyc llin (8, 36) . Mean perfusion pressu re was measured with a Statham transducer and a pen recorder. Effluent perfusate drained from a left ventricular cannula into a reservoir and was sampled from the outflow tubing for measurements of pH, PO*, and PCO~ with Corning microelectrodes. Perfusate pH was kept between 7.3 and 7.4 by addition of NaHC03 or HCl. Temperature of lungs and perfusate was maintained at 38OC. The lungs were equilibrated for 20 min before vascular reactivity was measured. Since ventilatory pressures and rate of flow were constant, an increase in perfusion pressure reflected pulmonary vasoconstriction. The maximal increase in pressure in response to a given stimulus was measured as the pressor response.
The first experiment examined the time course of the effect of ouabain (G-strophanthin, Sigma) on hypoxic pressor responses in blood-perfused lungs. Following an initial hypoxic challenge with 3% Oz-5% COZ-92% N2 (12, 21), four pressor responses to 7 min of 7% 0295% C02-88% N, were elicited at 15-min intervals. Five minutes after the first response to 7% 02, either saline (control) or low4 M ouabain was added to perfusate reservoir. (In this and all subseque nt cases '9 t he expression "X M of drug was added" means that the drug was added to the perfusate to achieve a final, circulating concentration of x M.) To test if effect of ouabain was specific for hypoxic vasoconstriction, a dose response to angiotensin II (Sigma) was elicited by bolus injections at 5-min intervals of 0.05-0.5 pg angiotensin II into the arterial line beginning 10 min after the fourth response to 7% o*.
The second experiment tested the effect of ouabain on the dose response to hypoxia and to KC1 in bloodperfused lungs. After an initial challenge with 3% OZ, saline (control), 5 x 10m5 M ouabain, or 10N4 M ouabain was added to the perfusate reservoir. Twenty minutes later a dose response to hypoxia was elicited by 7 min of ventilation with 10, 5, 3, and 0% 02-5%C02-balance N2 at 12-min intervals. In the control and low4 M ouabain groups a dose response to KC1 was elicited by adding from 1 to 10 mM KC1 to the perfusate reservoir at 5-min intervals beginning 10 min after the response to 0% OZ.
In a third experiment with blood-perfused lungs we tested whether inhibition of cyclooxygenase would prevent the effect of ouabain on the hypoxic dose response (3,36). Sodium meclofenamate (31 PM) was added to the blood at the beginning of perfusion, and the lungs were then studied in the same manner as those in the 10B4 M ouabain group of the second experiment.
In the fourth experiment we examined the effect of padrenergic blockade on the effect of ouabain on hypoxic vasoconstriction in salt-solution-perfused lungs (2, 24, 29). Following initial pressor challenges with 0.2 pg angiotensin II (20) and 3% 02, pressor responses to 7% O2 were measured before and after adding 5 x 10D6 M propranolol HCl (Ayerst) to the perfusate. Then, 20 min after addition of 10B4 M ouabain, the pressor response to 7% O2 was repeated.
The purpose of the fifth experiment was to test whether the effect of low-K+ perfusion on hypoxic vasoconstriction would be similar to that of ouabain. Lungs were first perfused with the standard physiological salt solution and stimulated alternatively at 3-min intervals with 0.5, 0.25, and 0.125 pg angiotensin II and 3 min of 0, 3, and 7% OZ. The perfusate was then exchanged for one in which KC1 and KH,P04 had been replaced by equimolar concentrations of NaCl and NaH2P04. Twelve minutes later the dose responses to angiotensin II and hypoxia were repeated. To learn if hypoxic reactivity would be restored by restimulation of the Na'-K+ pump, KC1 (5 mM) was then added back to the perfusate, and 20 min later the dose-response curves were elicited for a third time. Perfusate samples were collected during the midpoint of each maneuver for measurement of [K'] by flame photometry.
The purpose of the sixth experiment was to examine the effects of aldosterone, a stimulator of Na'-K+ pumping (7, 16, 23) , on the dose response to hypoxia and to angiotensin II. In salt solution-perfused lungs either aldosterone (2 x low6 M, Steroids) or 0.15% alcohol (solvent control) was added to the perfusate. Sixty minutes later (7) the lungs were challenged twice with 0.1 pg angiotensin II and 0% OZ. Dose responses to hypoxia and to angiotensin II were then measured.
The results are given as means t SE. They were evaluated statistically using two population or paired t tests or ANOVA with repeated measurements (31). Differences were considered significant at P < 0.05.
RESULTS
Addition of 10B4 M ouabain to blood-perfused lungs had no effect on base-line perfusion pressure but led within 18 min to inhibition of pressor responses to 7% AND HYPOXIC VASOCONSTRICTION O2 (Table 1) . After the last response to 7% O2 at 33 min after ouabain, the dose response to angiotensin II was slightly smaller in the ouabain group than in the controls (Fig. 1) . The inhibitory effects of two concentrations of ouabain on the hypoxic dose response are shown in Fig.  2 . The inhibition was related directly to concentration of ouabain and inversely to degree of hypoxia. In contrast to its blunting of the hypoxic dose response, lo-* M ouabain potentiated the subsequent dose response to KC1 (Fig. 3) striction was similar to that of ouabain. After 12 min of low-K+ perfusion (0.46 t 0.09 vs. 5.43 t 0.08 mM K', P c 0.05) in six lungs, the base-line perfusion pressure had increased from 6.7 t 0.3 to 8.1 t 0.4 Torr (P < 0.05), and the hypoxic dose response was blunted (Fig. 4) . The concomitant dose response to angiotensin II expressed as peak perfusion pressure was not different from control (Fig. 5) pressure had fallen to 7.5 t 0.6 Torr and the hypoxic pressor reactivity was increased, i.e., the hypoxic dose response during ventilation with 21, 7, 3, and 0% 02 was 7.5 t 0.6, 9.1 t 0.8, 10.5 t 0.9,. and 12.4 t 0.5 Torr, which was greater (P c 0.05, ANOVA) than that measured during low-K' perfusion (Fig. 4) . The accompanying dose response to angiotensin II, 7.5 2 0.6, 8.0 t 0.6, 8.4 t 0.6, and 8.9 t 0.8 Torr for 0, 0.125, 0.25, and 0.5 rug angiotensin II, was decreased (P < 0.05, ANOVA) compared with that elicited during low-K' perfusion (Fig. 5) .
In contrast to inhibition of hypoxic vasoconstriction by ouabain and low-K+ perfusate, aldosterone potentiated hypoxic pressure reactivity (Fig. 6) . Although baseline perfusion pressure after 60 min of perfusion was not different between control and aldosterone groups, it was slightly greater (P < 0.05) in aldosterone lungs at the be&&n.
of the hypoxic dose response (Fig. 6) , i.e., after the first two pressor challenges with angiotensin II and 0% Oz. Also during the course of the hypoxic dose re-J. HERGET AND I. F. McMURTRY sponse, the aldosterone group gained more in base-line perfusion pressure than did the control group so that the pressure at the beginning of the angiotensin II dose response was greater (P < 0.05) than that in control lungs (Fig. 7) . The dose response to angiotensin II in the aldosterone group was shifted in a parallel manner above that of the control group (Fig. 7) . ANOVA of the angiotensin II dose response expressed as absolute increases in perfusion pressure, ATorr, indicated no difference (P > 0.05) between control and aldosterone lungs, i.e., increases were 0.7 t 0.2, 2.2 t 0.6, 3.7 t 0.5, and 5.7 * 0.6 Torr in controls and 1.9 t 0.7, 2.6 & 0.5, 3.9 t 0.4, and 5.0 t 0.7 Torr in aldosterone lungs.
DISCUSSION
The results show that each of two inhibitors of Na+-K+-ATPase, ouabain and low [K'], depressed the dose response to hypoxia in isolated rat lungs. In contrast, a stimulator of Na+-K+ pumping, aldosterone, potentiated the hypoxic dose response. Although the effects of these modifiers of Na+-K+-ATPase activity were not specific for hypoxic vasoconstriction, they were also apparently not due to general, unidirectional changes in vascular reactivity. For example, whereas ouabain blunted severely the dose response to hypoxia, it had little effect on that to angiotensin II and actually potentiated the response to KCl. Similarly, aldosterone increased the steepness of the hypoxic dose response but resulted in an upward parallel shift of the dose response to angiotensin II. Thus it appears that in isolated rat lungs the mechanism of hypoxic vasoconstriction is at least more readily affected by changes in Na'-K+-ATPase activity than are the vasoconstrictor mechanisms of some other agents. We are unable to explain the varied action of ouabain on the pressor responses to angiotensin II and KCl.
In our studies 0.1 mM ouabain did not alter base-line perfusion pressure in either blood-or salt solution-perfused rat lungs. Low-K+ perfusion was associated with a small (~2 Torr) increase in perfusion pressure that was rapidly reversed on addition of 5 mM K+. These changes in vascular resistance in response to depletion and res- (13, 24, 37) . Because both 0.1 mM ouabain and low-K+ perfusion are associated with inhibition of Na+-K'-ATPase (37), the absence or relatively small degree of concomitant pulmonary vasoconstriction indica .tes tha t electrogenic Na+-K+ pumping does no t Play a major role in control ling vascular tone in isolated rat lungs. Thus our results provide no evidence for either of the ideas that inhibition of Na+-K+-ATPase will potentiate hypoxic vasoconstriction by depolarizing the vascular smooth muscle (10) or that decreased electrogenic Na+-K+ pumping in some lung cell is an initial event in the hypoxic mechanism. In fact, our studies suggest that hypoxic pressor reactivity is related positively, rather than inversely, to lung tissue Na'-K'-ATPase activity. Because we have no proof of the specificity of either ouabain, low K', or aldosterone, this suggestion and the subsequent discussion rest on the assumption that the observed effects were not due to some action other than alteration of Na+-K+-ATPase activity.
We do not have a conclusive explanation for why our results differ from those of Haas et al. (lo) , who observed that ouabain potentiated the pulm ,onary vasoconstrictor response to fractional inspired 02 (FIO,) = 6.1 in intact dogs and cats. Although the usual concerns about species differences could be raised, we have observed (unpublished data) that ouabain (2 mg/kg) also increases the pulmonary pressor response to FI 02 = 0.1 in intact rats. Thus the difference in effect of ouabain between the present study and that of Haas et al. (10) is perhaps due primari ly to diffe rences between in vitro and in vivo PrePa .rations. Some support for this possibility is provided by the observation that in dogs digoxin caused cyadrenergic pulmonary vasoconstriction that was mediated by systemic release of norepinephrine, rather than by direct action of digoxin in the lung (22). It should also be considered that because the degree of inhibition of hypoxic vasoconstriction in the isolated rat lung was dependent on both concentration of ouabain and severi of hypoxia, part of the difference between in vitro and *tY in vivo experiments may be due to differences in degree of inhibition of Na'-K'-ATPase and in level of hypoxic stimulus.
In addition to causing membrane depolarization and neurotransmitter release (2,6,34), inhibition of Na'-K'-ATPase by ouabain and low-K+ solution may lead to an increased production of cyclooxygenase metabolites (3), an increase in intracellular [Na'] (6, 17, 34, 35) , and decreased rates of cellular ATP hydrolysis and O2 consumption (9,14). The question arises, therefore, whether any of these effects are responsible for decreasing hypoxic pressor sensitivity in rat lungs. Because elevation of perfusate [K'], and pres umably membrane depolarization, potentiate hypoxic vasoconstriction in isolated lungs (1, 12), it seems unlikely that membrane depolarization associated with inhibition of Na+-K+ pumping could somehow have depressed the hypoxic mechanism. Similarly, because depression of hypoxic vasoconstriction by ouabain was not prevented by either propranolol (29) or to production cyclooxygenase (36).
of a vasodilator metabolite of Whether the depressed hypoxic sensitivity was in some way related to increased intracellular [Na+] is unknown. Inhibition of the tonic Ca2' influx-dependent phase of K+-induced contraction of taenia coli by ouabain has been attributed to either decreased Ca2' influx or increased Ca2+ efflux subsequent to elevated intracellular [Na+] (35). In our experiments, however, the blunted sensitivity to hypoxia in ouabain-exposed lungs was associated with an increased pressor reactivity to K+. On the other hand, we cannot rule out an unknown inhibitory effect, either direct or indirect, of increased intracellular [Na+] on the Ca2' influx, which is apparently cri tically important to the hypoxic mechani sm (21). If an increa sed intracel lular [ Na'] (or decreased transmembrane Na+ gradient) does somehow depress hypoxi .c vasoconstriction, then the potentiation by aldosterone could reasonably be due to decreased intracellular [Na'] (or increased Na+ gradient) (7).
As mentioned in the introduction, the effect of changes in Na'-K'-ATPase activity on cellular energy metabolism may be especially relevant to hypoxic pressor sensitivity. Assuming that the hypoxic mecha nism , involves an 02-sensing cell that detects a decrease in lu ng tissue O2 tension through slowing of mitochondrial oxidative phosphorylation and a fall in cytosolic [ATP]/[ADP]
[Pi] (4, 18, 26, 28), one could argue that decreased (ouabain and low-K') and increased (aldosterone) rates of ATP hydrolysis by Na+-K+-ATPase would, respectively, decrease and increase the metabolic and resultant pressor sensitivity to hypoxia. Although this is a reasonable speculation with which our results are consi stent, identification and direct measurements of energy metabolism in the theoretical 02-sen sing cell or tissue will be necessary to test its reality. A possible variation of this metabolic theme is that changes in Na'-K+ pumping could alter O2 consumption and diffusion gradient -at the "02 sensor" and thereby affect the fall in local O2 tension for a given decrease in airway 02 tension (15). Although Na+-K+-ATPase activity influences oxidative metabolism in many tissues (9, 14), a recent report suggests a closer link to rate of aerobic glycolysis in some vascular tissues (27) .
It is interesting to note that the effects on hypoxic vasoconstriction of the pharmacologic and ionic inhibitors and stimulator of Na+-K+ pumping observed in this study resemble those of decreased and increased temperature described in isolated lungs by Lloyd (19) and Nilsen and Hauge (25) . Perhaps inhibition of hypoxic pressor reactivity by cooling and potentiation by warming are related to depression and stimulation of Na+-K+ pumping, which is highly temperature sensitive. Another observation that may be relevant to our findings is that angiotensin II, which is particularly effective in inducing or potentiating hypoxic pressor reactivity in salt solution-perfused rat lungs (20), is a potent stimulator of Na' entry and Na+-K+ pump activity in cultured vascular smooth muscle (30).
or meclofenamate, it is unlikely that the depressed response was related either to ,&adrenergic stimulation
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